Resultados da pesquisa - Rafat Ansari

  • A mostrar 1 - 14 resultados de 14
Refinar resultados
  1. 1
    A high rate of venous thromboembolism in a multi‐institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

    A high rate of venous thromboembolism in a multi‐institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patie... Por Apurva A. Desai, Nicholas J. Vogelzang, Brian I. Rini, Rafat Ansari, S Krauß, Walter M. Stadler

    Publicado em 2002
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203

    Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203 Por Weijing Sun, Mark Powell, Peter J. O’Dwyer, Paul J. Catalano, Rafat Ansari, Al B. Benson

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study

    Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study Por Jinxing Li, Beth E. Juliar, Constantin T. Yiannoutsos, Rafat Ansari, Edward Fox, Michael Fisch, Lawrence H. Einhorn, Christopher J. Sweeney

    Publicado em 2005
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Phase II Trial of PS-341 in Patients With Renal Cell Cancer: A University of Chicago Phase II Consortium Study

    Phase II Trial of PS-341 in Patients With Renal Cell Cancer: A University of Chicago Phase II Consortium Study Por Nancy B. Davis, David Taber, Rafat Ansari, Christopher W. Ryan, Christopher George, Everett E. Vokes, Nicholas J. Vogelzang, Walter M. Stadler

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer

    Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer Por Chandra P. Belani, J. S. Lee, Mark A. Socinski, Francisco Robert, David Waterhouse, Kendrith M. Rowland, Rafat Ansari, Rogério Lilenbaum, Ronald B. Natale

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

    Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, place... Por Roy S. Herbst, Rafat Ansari, F. Bustin, Patrick J. Flynn, Lowell L. Hart, Gregory A. Otterson, Gordana Vlahovic, Chang-Heok Soh, Paula G. O’Connor, John D. Hainsworth

    Publicado em 2011
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer

    A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer Por Athanassios Argiris, Ezra E.W. Cohen, Theodore Karrison, Benjamin Esparaz, Ann M. Mauer, Rafat Ansari, Stuart J. Wong, Yi Fang Lu, Michael Pins, Janet Dancey, Everett E. Vokes

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT

    Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT Por Howard S. Höchster, Axel Grothey, L. Hart, Kendrith M. Rowland, Rafat Ansari, Steven R. Alberts, N. M. Chowhan, R. K. Ramanathan, Mark Keaton, John D. Hainsworth, Barrett H. Childs

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

    Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer Por Nasser H. Hanna, Paul A. Bunn, Corey J. Langer, Lawrence H. Einhorn, Troy H. Guthrie, Thaddeus Beck, Rafat Ansari, Peter Ellis, Michael Byrne, Mark E. Morrison, Hariharan Subramanian, Benjamin Wang, Alan Sandler

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer

    A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic no... Por Joseph Treat, R Gonin, Mark A. Socinski, Martin J. Edelman, Robert B. Catalano, Donna M. Marinucci, Rafat Ansari, H. H. Gillenwater, Kendrith M. Rowland, Robert L. Comis, Coleman K. Obasaju, Chandra P. Belani

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology

    Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or withou... Por Shadia I. Jalal, Heather Riggs, A. Melnyk, Donald Richards, Anuj K. Agarwala, M. Neubauer, Rafat Ansari, Ramaswamy Govindan, Daniel Bruetman, William B. Fisher, T. Breen, Cynthia S. Johnson, Menggang Yu, Lawrence H. Einhorn, Nasser H. Hanna

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401

    Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 Por Arti Hurria, Constance Cirrincione, Hyman B. Muss, Alice B. Kornblith, William T. Barry, Andrew Artz, Linda E. Schmieder, Rafat Ansari, William P. Tew, Douglas Weckstein, Jeffrey Kirshner, Kayo Togawa, Kurt Hansen, Vani Katheria, Richard M. Stone, Ilene Galinsky, John Postiglione, Harvey Jay Cohen

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer

    Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer Por Andrew D. Seidman, Adam Brufsky, Rafat Ansari, Lowell L. Hart, Richard S. Stein, Lee S. Schwartzberg, John F. Stewart, Christy Russell, Shu‐Ching Chen, Luis Fein, Jhony A. De La Cruz‐Vargas, S.-B. Kim, José Antônio Crespo Cavalheiro, Luping Zhao, John F. Gill, Coleman K. Obasaju, Mauro Orlando, D. F. Tai

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

    Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial Por Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Matthew J. Ellis, George W. Sledge, G. Thomas Budd, Manuela Rabaglio, Rafat Ansari, David B. Johnson, Richard Tozer, David D’Souza, Haji Chalchal, Silvana Spadafora, Vered Stearns, Edith A. Perez, Pedro Emanuel Rubini Liedke, István Láng, Catherine Elliott, Karen A. Gelmon, Judy-Anne W. Chapman, Lois E. Shepherd

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: